User:Mr. Ibrahem/Tirbanibulin

Tirbanibulin, sold under the brand name Klisyri, is a medication used to treat actinic keratosis of the face or scalp. It is used for five days in mild disease with reassessment after 8 weeks. It is applied to the skin.

Common side effects include local skin reactions, itchiness, and skin pain. Other side effects may include skin ulcers. There are concerns of harm when used during pregnancy in other animals; however, safety is human pregnancy is unclear. It is a microtubule inhibitor.

Tirbanibulin was approved for medical use in the United States in 2020 and Europe in 2021. In the United Kingdom a course of treatment costs the NHS about £60 as of 2022. This amount in the United States costs about 1,000 USD.